ULTRAGENYX PHARMACEUTICAL INC. Preferred Stock, Shares Authorized
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Preferred Stock, Shares Authorized of 25.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-05
- 2026-06-30: Preferred Stock, Shares Authorized 25.00M shares.
- 2026-03-31: Preferred Stock, Shares Authorized 25.00M shares.
- 2025-12-31: Preferred Stock, Shares Authorized 25.00M shares.
- 2025-09-30: Preferred Stock, Shares Authorized 25.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 25.00M shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 25.00M shares 10-Q · filed 2026-05-06 |
| 2025-12-31 | 25.00M shares 10-Q · filed 2026-08-05 |
| 2025-09-30 | 25.00M shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 25.00M shares 10-Q · filed 2025-08-06 |
| 2025-03-31 | 25.00M shares 10-Q · filed 2025-05-07 |
| 2024-12-31 | 25.00M shares 10-K · filed 2026-02-18 |
| 2024-09-30 | 25.00M shares 10-Q · filed 2024-11-06 |
| 2024-06-30 | 25.00M shares 10-Q · filed 2024-08-02 |
| 2024-03-31 | 25.00M shares 10-Q · filed 2024-05-03 |
| 2023-12-31 | 25.00M shares 10-K · filed 2025-02-19 |
| 2023-09-30 | 25.00M shares 10-Q · filed 2023-11-03 |
| 2023-06-30 | 25.00M shares 10-Q · filed 2023-08-04 |
| 2023-03-31 | 25.00M shares 10-Q · filed 2023-05-05 |
| 2022-12-31 | 25.00M shares 10-K · filed 2024-02-21 |
| 2022-09-30 | 25.00M shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 25.00M shares 10-Q · filed 2022-07-29 |
| 2022-03-31 | 25.00M shares 10-Q · filed 2022-05-06 |
| 2021-12-31 | 25.00M shares 10-K · filed 2023-02-17 |
| 2021-09-30 | 25.00M shares 10-Q · filed 2021-11-03 |
| 2021-06-30 | 25.00M shares 10-Q · filed 2021-08-03 |
| 2021-03-31 | 25.00M shares 10-Q · filed 2021-05-05 |
| 2020-12-31 | 25.00M shares 10-K · filed 2022-02-15 |
| 2020-09-30 | 25.00M shares 10-Q · filed 2020-10-27 |
| 2020-06-30 | 25.00M shares 10-Q · filed 2020-07-30 |
| 2020-03-31 | 25.00M shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 25.00M shares 10-K · filed 2021-02-12 |
| 2019-09-30 | 25.00M shares 10-Q · filed 2019-11-06 |
| 2019-06-30 | 25.00M shares 10-Q · filed 2019-08-02 |
| 2019-03-31 | 25.00M shares 10-Q · filed 2019-05-07 |
| 2018-12-31 | 25.00M shares 10-K · filed 2020-02-14 |
| 2018-09-30 | 25.00M shares 10-Q · filed 2018-11-06 |
| 2018-06-30 | 25.00M shares 10-Q · filed 2018-08-03 |
| 2018-03-31 | 25.00M shares 10-Q · filed 2018-05-08 |
| 2017-12-31 | 25.00M shares 10-K · filed 2019-02-20 |
| 2017-09-30 | 25.00M shares 10-Q · filed 2017-11-03 |
| 2017-06-30 | 25.00M shares 10-Q · filed 2017-07-28 |
| 2017-03-31 | 25.00M shares 10-Q · filed 2017-05-05 |
| 2016-12-31 | 25.00M shares 10-K · filed 2018-02-21 |
| 2016-09-30 | 25.00M shares 10-Q · filed 2016-11-08 |
| 2016-06-30 | 25.00M shares 10-Q · filed 2016-08-09 |
| 2016-03-31 | 25.00M shares 10-Q · filed 2016-05-10 |
| 2015-12-31 | 25.00M shares 10-K · filed 2017-02-17 |
| 2015-09-30 | 25.00M shares 10-Q · filed 2015-11-10 |
| 2015-06-30 | 25.00M shares 10-Q · filed 2015-08-14 |
| 2015-03-31 | 25.00M shares 10-Q · filed 2015-05-12 |
| 2014-12-31 | 25.00M shares 10-K · filed 2016-02-26 |
| 2014-09-30 | 25.00M shares 10-Q · filed 2014-11-10 |
| 2014-06-30 | 25.00M shares 10-Q · filed 2014-08-11 |
| 2014-03-31 | 25.00M shares 10-Q · filed 2014-05-12 |
| 2013-12-31 | 25.00M shares 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |